## **Core Concept**
The question tests knowledge of pharmacological management of anxiety disorders, specifically severe anxiety disorder with intermittent panic attacks. The treatment often involves medications that can provide sustained anxiolytic effects with a favorable side-effect profile for long-term use.

## **Why the Correct Answer is Right**
The correct answer, , is preferred for the long-term treatment of severe anxiety disorder with intermittent panic attacks because it is a selective serotonin reuptake inhibitor (SSRI). SSRIs are considered first-line treatments for various anxiety disorders, including generalized anxiety disorder (GAD) and panic disorder, due to their efficacy, relatively favorable side-effect profile, and lower potential for abuse compared to other anxiolytic agents like benzodiazepines.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because, although it is an SSRI and effective for depression and some anxiety disorders, it might not be the first choice for panic disorder due to its side effects and the availability of better-tolerated alternatives.
- **Option B:** is incorrect because it is a benzodiazepine, which, while effective for short-term relief of anxiety, is generally not recommended for long-term treatment due to the risk of dependence, tolerance, and withdrawal symptoms.
- **Option C:** is incorrect because, although it could be an option for certain types of anxiety or depression, it is not specifically indicated as a first-line treatment for severe anxiety with panic attacks compared to SSRIs.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that SSRIs are often the preferred class of medications for the long-term management of anxiety disorders, including those with panic attacks, due to their efficacy and safety profile. Benzodiazepines, while useful in acute settings, are generally recommended for short-term use (<4 weeks) to minimize risks of dependence. ## **Correct Answer:** .